Kenya AIDS Vaccine Initiative (KAVI) : a Centre of Excellence for East Africa

This project is a joint initiative between the University of Nairobi, Kenya, and the universities of Manitoba and Toronto, Canada. The overall objective is to establish the Kenya Aids Vaccine Initiative (KAVI) as a centre of excellence for training healthcare professionals for HIV vaccine and other prevention trials in East Africa. KAVI will offer training in epidemiology, research design, immunology, good clinical practice, good clinical laboratory practice, data management and cohort establishment. Basic science training will take place in Kenya and Canada, with an emphasis on technology transfer. The project will also endeavor to build vaccine literacy and acceptance on the part of local communities, policymakers and other stakeholders; enhance the capacity of local ethics review boards and institutional administrators to handle issues raised by vaccine trials; and enhance the ability of KAVI to bid in competitions for independent research funding for clinical trials.

Project ID

106351

Project status

Closed

Start Date

Friday, September 10, 2010

End Date

Wednesday, December 31, 2014

Duration

41 months

IDRC Officer

Cohen, Marc

Total funding

CA$ 1,443,304

Countries

North of Sahara, South of Sahara, Kenya, Canada

Program

Maternal and Child Health

Project Leader

Dr. Rupert Kaul

Project Leader

Professor Omu Anzala

Institution

University of Nairobi

Institution Country

Kenya

Institution Website

http://www.uonbi.ac.ke